id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-318755-fip8wj6y	El Kassas, Mohamed	Liver transplantation in the era of COVID-19	2020-05-12		.txt	text/plain	4268	221	38	Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. Although healthcare facilities are overwhelmed with management of COVID-19 patients & health resources are being rapidly consumed, the American Association for the Study of Liver Diseases (AASLD), recommended against postponing transplantation. Patients with advanced liver disease and those after LTX represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19 Because of the immunosuppressed state they have [59] . Available data on coronavirus before and during outbreaks suggest that immunosuppressed patients are not at increased risk of severe pulmonary disease compared to the general population; however, immunosuppression may prolong viral shedding in post-transplant patients with COVID-19 if they are already infected [36, 60] .	./cache/cord-318755-fip8wj6y.txt	./txt/cord-318755-fip8wj6y.txt